Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Reason #3 to why trial sites were removed. I previously speculated 1) it's a paperwork thing and 2) keep the trial sites close to the vest so competitors will have to do their own legwork. This possibly could be true but sounds funny to me now. So reason #3 is that they removed the list of trial sited because they are embarrassed that they still have not opened any trial sites in the EU? The thought came to me when I took a look at Array's metastatic Colorectal cancer (mCRC) trial I mentioned in post 2343 and it shows all 240 international Study Locations. That's something to be proud of. Perhaps Spectrum is embarrassed that the EU sites are still not up and running? Spectrum, EXECUTUTE on your goals please!